DOCSLIB.ORG

Plasticity of Reward Neurocircuitry and the 'Dark Side' of Drug Addiction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Plasticity of Reward Neurocircuitry and the 'Dark Side' of Drug Addiction COMMENTARY NEUROBIOLOGY OF ADDICTION Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction George F Koob & Michel Le Moal Drug seeking is associated with activation of reward neural circuitry. Here we argue that drug addiction also involves a ‘dark side’—a decrease in the function of normal reward-related neurocircuitry and persistent recruitment of anti-reward systems. Understanding the neuroplasticity of the dark side of this circuitry is the key to understanding vulnerability to addiction. Drug addiction has been conceptualized as tive and sensitization framework) can be super- theoretical positions favor models from each of http://www.nature.com/natureneuroscience a progression from impulsive to compulsive imposed on the stages of the addiction cycle2. the three stages, although in our view, models behavior, ending in chronic, relapsing drug These stages are thought to feed into each other, of the transition to dependence have the most taking. Patients with impulse control disor- becoming more intense and ultimately leading heuristic value for the human condition. ders experience an increasing sense of tension to the pathological state known as addiction. For the binge-intoxication stage, studies of or arousal before committing an impulsive Our thesis is that addiction involves a long- the acute reinforcing effects of drugs of abuse act; pleasure, gratification or relief at the time term, persistent plasticity in the activity of per se have identified key neurobiological sub- of committing the act; and then regret, self- neural circuits mediating two different moti- strates. Important anatomical circuits include reproach or guilt after the act1. In contrast, vational systems: decreased function of brain the mesocorticolimbic dopamine system patients with compulsive disorders experience reward systems driven by natural rewards, and originating in the ventral tegmental area and anxiety and stress before committing a com- recruitment of anti-reward systems that drive projecting to the nucleus accumbens and the pulsive repetitive behavior, then relief from the aversive states. The concept of anti-reward is extended amygdala. The extended amygdala stress by performing the behavior1. In addic- based on the hypothesis that there are brain comprises the central nucleus of the amygdala, 2005 Nature Publishing Group Group 2005 Nature Publishing tion, drug-taking behavior progresses from systems in place to limit reward (see footnote the bed nucleus of the stria terminalis and a © impulsivity to compulsivity in a three-stage in ref. 2), an ‘opponent process’ concept that is transition area in the medial (shell) part of the cycle: binge/intoxication, withdrawal/negative a general feature of biological systems3. nucleus accumbens and a major projection to affect and preoccupation/anticipation2. In the From a neurobiological perspective, progres- the lateral hypothalamus. Neurotransmitter/ impulsive stage, the drive for the drug-taking sion through the three stages of the addiction neuromodulator systems implicated in the behavior is positive reinforcement, in which cycle induces plasticity in neural circuitry that acute reinforcing effects of drugs of abuse in stimuli increase the probability of the response. drives compulsive drug taking, narrowing the these neuroanatomical sites include dopamine, As individuals move to the compulsive stage, the behavioral repertoire to drug seeking. Animal opioid peptides, γ-aminobutyric acid (GABA), drive transitions to negative reinforcement, in models have been developed that have face glutamate, neuropeptide Y and glucocorticoids which removal of the aversive state increases the validity (resembles the human condition) and of the hypothalamic-pituitary-adrenal (HPA) probability of the response. Different theoreti- some construct validity (possesses explanatory axis5. There is strong evidence for a role of cal perspectives from experimental psychology power) for all three stages of the addiction cycle dopamine in the acute reinforcing actions of (positive and negative reinforcement frame- and the transition to drug addiction. Acute self- psychostimulants, for opioid peptide receptors work), social psychology (self-regulation failure administration of drugs (intravenous and oral) in the acute reinforcing effects of opioids, and framework) and neurobiology (counteradap- has construct validity for drug intoxication and for GABA and opioid peptides in the acute rein- elements of drug binges in humans. Self-stim- forcing actions of alcohol. Although acute drug ulation and place conditioning (learning to use is not, in and of itself, addiction, the study George F. Koob is in the Molecular and Integrative avoid a location previously paired with an aver- of the neuropharmacological mechanisms for Neurosciences Department, The Scripps sive stimulus or state) are sensitive measures the acute reinforcing effects of drugs of abuse Research Institute, La Jolla, California, 92037, of ‘motivational’ withdrawal. Cue-induced or has had heuristic value in two major domains. USA, and Michel Le Moal is at the Laboratoire de stress-induced reinstatement has face validity Such studies provide a framework for examin- Physiopathologie des Comportements, Institut and is currently under test for construct valid- ing neuroadaptive changes in the reward circuits National de la Santé et de la Recherche Médicale, ity. Although more construct validation rela- with the development of addiction, and they Unite 588, Université Victor Segalen Bordeaux 2, tive to the human condition is needed, neural also provide a valid model for development of Bordeaux, France. substrates for each of the stages have already medications to treat excessive drug intake (such e-mail: [email protected] been identified using these models4. Different as naltrexone for excessive drinking). 1442 VOLUME 8 | NUMBER 11 | NOVEMBER 2005 NATURE NEUROSCIENCE COMMENTARY For the purposes of this opinion piece, the provides a powerful source of negative rein- source of potential allostatic changes that drive withdrawal/negative affect stage can be defined forcement that defines compulsive drug-seek- and maintain addiction2. In this context, ‘allo- as the presence of motivational signs of with- ing behavior and addiction. The development stasis’ is defined as the process of achieving drawal in humans: chronic irritability, emo- of the aversive emotional state that drives the stability of the reward system through change. tional pain, malaise, dysphoria, alexithymia negative reinforcement of addiction is here An allostatic state is a state of chronic deviation and loss of motivation for natural rewards. It is termed the ‘dark side’ of addiction. We further of the reward system from its normal (homeo- characterized in animals by increases in reward hypothesize that this chronic aversive state static) operating level, which ultimately leads thresholds during withdrawal from all major manifested by motivational signs of withdrawal to the pathological state of addiction. More drugs of abuse. Significant plasticity occurs in in humans is produced in part by recruitment specifically, in drug addiction, allostasis is the the neurotransmitter circuits identified above of the brain anti-reward systems. We believe process of attempting to maintain apparent as critical for the acute reinforcing effects of that research in this domain has been largely reward function stability by changes in reward drugs of abuse. In animal models of the tran- neglected by the field, mainly because of an and anti-reward system neurocircuitry5. sition to addiction, similar changes in brain excessive focus on psychostimulant drugs and Neuroplasticity in the natural reward sys- reward threshold occur that temporally precede reward pathways (largely misattributed to the tem is highlighted by decreased dopaminergic and highly correlate with escalation in drug mesolimbic dopamine system). activity and hypofrontality. Neuroplasticity intake6. During such acute withdrawal, there A critical problem in drug addiction is in the anti-reward system is highlighted by is decreased activity of the mesocorticolimbic chronic relapse, in which addicts return to increased CRF function and is hypothesized dopamine system as measured by electrophysi- compulsive drug taking long after acute with- to be particularly slow to return to homeosta- ological recordings and in vivo microdialysis, drawal. This corresponds to the preoccupation/ sis. This makes the system that drives the dark and there is also decreased activity in opioid anticipation stage of the addiction cycle, out- side potentially more important for driving peptide, GABA, glutamate and neuropeptide Y lined above. Both animal and human neuro- dependence than decreases in natural reward in elements of the extended amygdala and/or imaging studies show that the prefrontal cortex function. For example, there is evidence of nucleus accumbens. Human imaging studies system (orbitofrontal, medial prefrontal, pre- residual dysregulation of the HPA axis16 and of http://www.nature.com/natureneuroscience of addicts during withdrawal or protracted limbic/cingulate) and the basolateral amygdala the brain CRF system weeks after acute with- abstinence give results that are consistent are key mediators of drug- and cue-induced drawal from alcohol17. Similar observations with the animal studies, including decreases reinstatement in animal models and craving are made in human addicts18. In contrast, in dopamine D2 receptors (hypothesized to and relapse
Load more

Recommended publications
  • Targeting Neuroplasticity for Balance Or Gait Deficit
    August 2021 Volume 1 Issue 8 CADTH Horizon Scan The Portable Neuromodulation Stimulator: Targeting Neuroplasticity for Balance or Gait Deficit Health Technology Update Authors: Sara D. Khangura ISSN: 2563-6596 Disclaimer: The information in this document is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. While patients and others may access this document, the document is made available for informational purposes only and no representations or warranties are made with respect to its fitness for any particular purpose. The information in this document should not be used as a substitute for professional medical advice or as a substitute for the application of clinical judgment in respect of the care of a particular patient or other professional judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services. While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up to date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document. The views and opinions of third parties published in this document do not necessarily state or reflect those of CADTH.
    [Show full text]
  • The Creation of Neuroscience
    The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits.
    [Show full text]
  • Brain Stimulation and Neuroplasticity
    brain sciences Editorial Brain Stimulation and Neuroplasticity Ulrich Palm 1,2,* , Moussa A. Chalah 3,4 and Samar S. Ayache 3,4 1 Department of Psychiatry and Psychotherapy, Klinikum der Universität München, 80336 Munich, Germany 2 Medical Park Chiemseeblick, Rasthausstr. 25, 83233 Bernau-Felden, Germany 3 EA4391 Excitabilité Nerveuse & Thérapeutique, Université Paris Est Créteil, 94010 Créteil, France; [email protected] (M.A.C.); [email protected] (S.S.A.) 4 Service de Physiologie—Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique—Hôpitaux de Paris, 94010 Créteil, France * Correspondence: [email protected] Electrical or magnetic stimulation methods for brain or nerve modulation have been widely known for centuries, beginning with the Atlantic torpedo fish for the treatment of headaches in ancient Greece, followed by Luigi Galvani’s experiments with frog legs in baroque Italy, and leading to the interventional use of brain stimulation methods across Europe in the 19th century. However, actual research focusing on the development of tran- scranial magnetic stimulation (TMS) is beginning in the 1980s and transcranial electrical brain stimulation methods, such as transcranial direct current stimulation (tDCS), tran- scranial alternating current stimulation (tACS), and transcranial random noise stimulation (tRNS), are investigated from around the year 2000. Today, electrical, or magnetic stimulation methods are used for either the diagnosis or exploration of neurophysiology and neuroplasticity functions, or as a therapeutic interven- tion in neurologic or psychiatric disorders (i.e., structural damage or functional impairment of central or peripheral nerve function). This Special Issue ‘Brain Stimulation and Neuroplasticity’ gathers ten research articles Citation: Palm, U.; Chalah, M.A.; and two review articles on various magnetic and electrical brain stimulation methods in Ayache, S.S.
    [Show full text]
  • How Drugs Affect the Brain and Medication‐Assisted Treatment
    How Drugs Affect the Brain And Medication‐Assisted Treatment Presented by Carl M. Dawson, M.S., MAC, LPC, Q‐SAP Learning Objectives After completing this section, participants will be able to: • Understand the scientific modalities neuroscientists use when studying addictions (Bio‐Psycho‐Social model of addictions, genetics and neuroplasticity) • Explore basic facts regarding the development and function of the human brain • Identify three “Feel Good” chemicals released by the brain (dopamine, serotonin, norepinephrine) • Discuss how addictive behaviors and drugs routinely “hijack” the human brain How Neuroscientists Study Addiction • All addictions (alcohol, drugs, gambling, porn, video games, food) activate the same neurological pleasure (reward) routes (pathways) in the brain • Addictionology uses the “Bio‐Psycho‐Social” model when studying addictions • Research has identified a strong genetic basis for all addiction behaviors (There is no single “addiction” gene, there are approx. 90 genes associated with addictions) How Neuroscientists Study Addiction • Remember: “Our genetics load the gun, but the environment pulls the trigger” • Addictions aren't only hijacking the brain’s activities but they have the ability to modify the neurological structures and activities of the brain (neuroplasticity) Neuroplasticity: is a term used in the field of neuroscience that defines the brain's ability to adapt, adjust and change based upon the strength and reward of the experience ‐ “Neurons that Fire Together, Wire Together” Donald O. Hebb (1904‐1985) Basic Facts and Regions of the Human Brain The average human brain weighs approximately three (3 lbs.) pounds, consisting of 60% protein (fat), possessing approximately 85 to 110 billion neurons and produces 15 watts of electricity, traveling at a speed of one‐half to 250 miles per hour Approximate Ages of the Human Brain 7,000 7,000 480,000 6 to 10 mil.
    [Show full text]
  • The Brain That Changes Itself
    The Brain That Changes Itself Stories of Personal Triumph from the Frontiers of Brain Science NORMAN DOIDGE, M.D. For Eugene L. Goldberg, M.D., because you said you might like to read it Contents 1 A Woman Perpetually Falling . Rescued by the Man Who Discovered the Plasticity of Our Senses 2 Building Herself a Better Brain A Woman Labeled "Retarded" Discovers How to Heal Herself 3 Redesigning the Brain A Scientist Changes Brains to Sharpen Perception and Memory, Increase Speed of Thought, and Heal Learning Problems 4 Acquiring Tastes and Loves What Neuroplasticity Teaches Us About Sexual Attraction and Love 5 Midnight Resurrections Stroke Victims Learn to Move and Speak Again 6 Brain Lock Unlocked Using Plasticity to Stop Worries, OPsessions, Compulsions, and Bad Habits 7 Pain The Dark Side of Plasticity 8 Imagination How Thinking Makes It So 9 Turning Our Ghosts into Ancestors Psychoanalysis as a Neuroplastic Therapy 10 Rejuvenation The Discovery of the Neuronal Stem Cell and Lessons for Preserving Our Brains 11 More than the Sum of Her Parts A Woman Shows Us How Radically Plastic the Brain Can Be Appendix 1 The Culturally Modified Brain Appendix 2 Plasticity and the Idea of Progress Note to the Reader All the names of people who have undergone neuroplastic transformations are real, except in the few places indicated, and in the cases of children and their families. The Notes and References section at the end of the book includes comments on both the chapters and the appendices. Preface This book is about the revolutionary discovery that the human brain can change itself, as told through the stories of the scientists, doctors, and patients who have together brought about these astonishing transformations.
    [Show full text]
  • Michael M. Merzenich
    Michael M. Merzenich BORN: Lebanon, Oregon May 15, 1942 EDUCATION: Public Schools, Lebanon, Oregon (1924–1935) University of Portland (Oregon), B.S. (1965) Johns Hopkins University, Ph.D. (1968) University of Wisconsin Postdoctoral Fellow (1968–1971) APPOINTMENTS: Assistant and Associate Professor, University of California at San Francisco (1971–1980) Francis A. Sooy Professor, University of California at San Francisco (1981–2008) President and CEO, Scientifi c Learning Corporation (1995–1996) Chief Scientifi c Offi cer, Scientifi c Learning Corporation (1996–2003) Chief Scientifi c Offi cer, Posit Science Corporation (2004–present) President and CEO, Brain Plasticity Institute (2008–present) HONORS AND AWARDS (SELECTED): Cortical Discoverer Prize, Cajal Club (1994) IPSEN Prize (Paris, 1997) Zotterman Prize (Stockholm, 1998) Craik Prize (Cambridge, 1998) National Academy of Sciences, U.S.A. (1999) Lashley Award, American Philosophical Society (1999) Thomas Edison Prize (Menlo Park, NJ, 2000) American Psychological Society Distinguished Scientifi c Contribution Award (2001) Zülch Prize, Max-Planck Society (2002) Genius Award, Cure Autism Now (2002) Purkinje Medal, Czech Academy (2003) Neurotechnologist of the Year (2006) Institute of Medicine (2008) Michael M. Merzenich has conducted studies defi ning the functional organization of the auditory and somatosensory nervous systems. Initial models of a commercially successful cochlear implant (now distributed by Boston Scientifi c) were developed in his laboratory. Seminal research on cortical plasticity conducted in his laboratory contributed to our current understanding of the phenomenology of brain plasticity across the human lifetime. Merzenich extended this research into the commercial world by co-founding three brain plasticity-based therapeutic software companies (Scientifi c Learning, Posit Science, and Brain Plasticity Institute).
    [Show full text]
  • Protocol Title: Cracking Addiction
    Protocol Title: Cracking addiction: does BRAIN Stimulation-induced neuroplasticity reverse prefrontal cortex hypoactivity in cocaine and neW stImulanTs addiCtion in Humans (BRAIN SWITCH)? Abbreviated title: Transcranial Magnetic Stimulation for Cocaine Addiction Protocol Number: 1496 Date of Approval: June 29, 2017 Principal Investigator Name, Degree Branch/Institute Phone E-mail Massimo di Dept. of +39 0871358928 [email protected] Giannantonio, Neuroscience, MD Imaging and Clinical Sciences (ITAB) – University of Chieti Co- Principal Investigator Name, Degree Branch/Institute Phone E-mail Giovanni Dept. of +39 08713556914 [email protected] Martinotti, M.D., Neuroscience, Ph.D. Imaging and Clinical Sciences (ITAB) – University of Chieti Villa Maria Pia Clinic - Rome Associate Investigators Name, Degree Branch/Institute Phone E-mail Chiara MNB/NINDS +39 3281264713 [email protected] Montemitro, M.D. Mauro MNB/NINDS +39 3391979487 [email protected] Pettorruso, M.D. Lamberto Office of +39 3474727282 [email protected] Manzoli, Ph.D. Biostatistics/ University of Ferrara Referral Contact Name, Degree Branch/Institute Phone E-mail Mauro Pettorruso, MNB/NINDS +39 3391979487 [email protected] M.D. 1 Accountable Investigator Name, Degree Branch/Institute Phone E-mail Giovanni Dept. of +39 08713556914 [email protected] Martinotti, M.D., Neuroscience, Ph.D. Imaging and Clinical Sciences (ITAB) – University of Chieti Villa Maria Pia Clinic - Rome 2 A. Précis Background: Cocaine use disorder (CUD) are a major public health concern, associated with high relapse rates, significant disability and substantial mortality. In Italy, it has been recently estimated that up to 4.8% of subjects between the ages of 15-64 have assumed cocaine at least once, whereas 1.3% subjects currently have a diagnosis of CUD.
    [Show full text]
  • Gut Microbiota and Neuroplasticity
    cells Review Gut Microbiota and Neuroplasticity Julia Murciano-Brea 1,2, Martin Garcia-Montes 1,2, Stefano Geuna 3 and Celia Herrera-Rincon 1,2,* 1 Department of Biodiversity, Ecology & Evolution, Biomathematics Unit, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] (J.M.-B.); [email protected] (M.G.-M.) 2 Modeling, Data Analysis and Computational Tools for Biology Research Group, Complutense University of Madrid, 28040 Madrid, Spain 3 Department of Clinical and Biological Sciences, School of Medicine, University of Torino, 10124 Torino, Italy; [email protected] * Correspondence: [email protected]; Tel.: +34-91394-4888 Abstract: The accumulating evidence linking bacteria in the gut and neurons in the brain (the microbiota–gut–brain axis) has led to a paradigm shift in the neurosciences. Understanding the neurobiological mechanisms supporting the relevance of actions mediated by the gut microbiota for brain physiology and neuronal functioning is a key research area. In this review, we discuss the literature showing how the microbiota is emerging as a key regulator of the brain’s function and behavior, as increasing amounts of evidence on the importance of the bidirectional communication between the intestinal bacteria and the brain have accumulated. Based on recent discoveries, we suggest that the interaction between diet and the gut microbiota, which might ultimately affect the brain, represents an unprecedented stimulus for conducting new research that links food and mood. We also review the limited work in the clinical arena to date, and we propose novel approaches for deciphering the gut microbiota–brain axis and, eventually, for manipulating this relationship to boost mental wellness.
    [Show full text]
  • Neural Plasticity in the Brain During Neuropathic Pain
    biomedicines Review Neural Plasticity in the Brain during Neuropathic Pain Myeong Seong Bak 1, Haney Park 1 and Sun Kwang Kim 1,2,* 1 Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea; [email protected] (M.S.B.); [email protected] (H.P.) 2 Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea * Correspondence: [email protected]; Tel.: +82-2-961-0491 Abstract: Neuropathic pain is an intractable chronic pain, caused by damage to the somatosensory nervous system. To date, treatment for neuropathic pain has limited effects. For the development of efficient therapeutic methods, it is essential to fully understand the pathological mechanisms of neuropathic pain. Besides abnormal sensitization in the periphery and spinal cord, accumulating evidence suggests that neural plasticity in the brain is also critical for the development and mainte- nance of this pain. Recent technological advances in the measurement and manipulation of neuronal activity allow us to understand maladaptive plastic changes in the brain during neuropathic pain more precisely and modulate brain activity to reverse pain states at the preclinical and clinical levels. In this review paper, we discuss the current understanding of pathological neural plasticity in the four pain-related brain areas: the primary somatosensory cortex, the anterior cingulate cortex, the periaqueductal gray, and the basal ganglia. We also discuss potential treatments for neuropathic pain based on the modulation of neural plasticity in these brain areas. Keywords: neuropathic pain; neural plasticity; primary somatosensory cortex; anterior cingulate cortex; periaqueductal grey; basal ganglia Citation: Bak, M.S.; Park, H.; Kim, S.K.
    [Show full text]
  • The Portable Neuromodulation Stimulator (Pons)
    The Portable Neuromodulation Stimulator (PoNS™) FACT SHEET What is the PoNS? The Portable Neuromodulation Stimulator (PoNS) device is an investigational medical device being studied for the treatment of neurological symptoms caused by disease or trauma. The PoNS is currently being studied in the United States for the treatment of balance disorder related to mild to moderate Traumatic Brain Injury (mTBI), and in Canada for the treatment of gait and balance disorder for patients with Multiple Sclerosis (MS). It represents the first in a series of non-invasive devices -- based on the patented PoNS platform -- designed to amplify the brain’s powerful ability to heal itself. This is part of a new approach being studied for “symptom treatment” for the rising number of patients who have experienced loss of function as a result of neurological disease or trauma. What is the potential impact of the PoNS? As a result of their disease or injury, many patients are left with disrupted neural networks in the brain that are unable to carry neural impulses completely or efficiently. Neural impulses are the signals responsible for directing the functions of the body, such as movement control or sensory perception. Researchers believe that significantly increasing the activation of these neurons through electrical stimulation, combined with targeted functional therapy, may help reorganize and reactivate the networks responsible for those functions. While physicians and patients turn to available options to manage a host of neurological symptoms today, for millions living with these chronic disorders, there exists limited treatment options that actually help patients rehabilitate lost functions. The PoNS device is being studied as new potential option for the treatment of these chronic neurological symptoms of disease or trauma.
    [Show full text]
  • Neuroscience Discoveries and Clinical Practice Resource List
    TENTH ANNUAL INTERPROFESSIONAL Spring Symposium Neuroscience Discoveries and Clinical Practice Resource List A list of resources prepared by UNE Library Services Books Addiction Neuroethics: The Ethics of Cognitive Neuroscience Addiction Neuroscience Research and Marie T. Banich and Rebecca J. Compton Treatment Wadsworth, Cengage Learning, 2010 Adrian Carter Academic Press, 2011 Addiction Neuroethics: The Promises and Cognitive Neuroscience of Aging: Linking Perils of Neuroscience Research on Addiction Cognitive and Cerebral Aging Adrian Carter Roberto Cabeza, Lars Nyberg, & Denise Park Cambridge University Press, 2012 Oxford University Press, 2009 Advances in the Neuroscience of Addiction The Compass of Pleasure: How Our Brains Cynthia M. Kuhn, George F. Koob Make Fatty Foods, Orgasm, Exercise, CRC Press, 2010 Marijuana, Generosity, Vodka, Learning, and Gambling Feel So Good David J. Linden Viking, c2011 Art Therapy and Clinical Neuroscience Creating Modern Neuroscience : The Revolu- Noah Hass-Cohen and Richard Carr tionary 1950s Jessica Kingsley Publishers, 2008 Gordon M. Shepherd Oxford University Press, 2010 The Behavioral Neuroscience of Empathy: From Bench to Bedside Adolescence Jean Decety Linda Patia Spear MIT, 2011 W. W. Norton, c2010 Brain Culture: Neuroscience and Essential Neuroscience Popular Media Allan Siegel and Hreday N. Sapru Davi Johnson Thornton Wolters Kluwer/Lippincott Williams & Wilkins Rutgers University Press, 2011 Health, c2011 Braintrust: What Neuroscience Tells Us Foundations of Behavioral Neuroscience about Morality Neil R. Carlson Patricia S. Churchland Prentice Hall, 2010 Princeton University Press, 2011 Cajal’s Butterflies of the Soul: Science From Brain to Mind: Using Neuroscience to and Art Guide Change in Education Javier DeFelipe James E. Zull Oxford University Press, 2010 Stylus, 2011 Clinical Neuroscience: Psychopathology Fundamentals of Computational and the Brain Neuroscience Kelly G.
    [Show full text]
  • Brain-Machine Interface: from Neurophysiology to Clinical
    Neurophysiology of Brain-Machine Interface Rehabilitation Matija Milosevic, Osaka University - Graduate School of Engineering Science - Japan. Abstract— Long-lasting cortical re-organization or II. METHODS neuroplasticity depends on the ability to synchronize the descending (voluntary) commands and the successful execution Stimulation of muscles with FES was delivered using a of the task using a neuroprosthetic. This talk will discuss the constant current biphasic waveform with a 300μs pulse width neurophysiological mechanisms of brain-machine interface at 50 Hz frequency via surface electrodes. First, repetitive (BMI) controlled neuroprosthetics with the aim to provide transcranial magnetic stimulation (rTMS) intermittent theta implications for development of technologies for rehabilitation. burst protocol (iTBS) was used to induce cortical facilitation. iTBS protocol consists of pulses delivered intermittently at a I. INTRODUCTION frequency of 50 Hz and 5 Hz for a total of 200 seconds. Functional electrical stimulation (FES) neuroprosthetics Moreover, motor imagery protocol was used to display a can be used to applying short electric impulses over the virtual reality hand opening and closing sequence of muscles or the nerves to generate hand muscle contractions movements (hand flexion/extension) while subject’s hands and functional movements such as reaching and grasping. remained at rest and out of the visual field. Our work has shown that recruitment of muscles using FES goes beyond simple contractions, with evidence suggesting III. RESULTS re-organization of the spinal reflex networks and cortical- Our first results showed that motor imagery can affect level changes after the stimulating period [1,2]. However, a major challenge remains in achieving precise temporal corticospinal facilitation in a phase-dependent manner, i.e., synchronization of voluntary commands and activation of the hand flexor muscles during hand closing and extensor muscles [3].
    [Show full text]